External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Accelerating Growth in the Blends Segment: The Blends division reported a healthy performance across major markets, led by strong traction in the CFS Vitafor portfolio.</li><li>Segment revenue increased 6% YoY to Rs 239 Cr (vs Rs 226 Cr in Q2FY25).</li><li>Management remains optimistic about the division’s growth prospects, projecting a ~20% CAGR over the next 2–3 years, supported by network expansion, deeper geographic reach, improved order visibility, and potential inorganic opportunities.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Accelerating Growth in the Blends Segment: The Blends division reported a healthy performance across major markets, led by strong traction in the CFS Vitafor portfolio.Segment revenue increased 6% YoY to Rs 239 Cr (vs Rs 226 Cr in Q2FY25).Management remains optimistic about the division’s growth prospects, projecting a ~20% CAGR over the next 2–3 years, supported by network expansion, deeper geographic reach, improved order visibility, and potential inorganic opportunities.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Camlin Fine Sciences Ltd. - Margin Recovery Still Distant